Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 4:03 pm Purchase | 2022-12-31 | 13G | Y-mAbs Therapeutics, Inc. YMAB | HBM Healthcare Investments (Cayman) Ltd. | 3,813,853 8.700% | 722,899 (+23.39%) | Filing History |
| 2023-02-14 1:50 pm Purchase | 2019-12-31 | 13G | Y-mAbs Therapeutics, Inc. YMAB | WG Biotech ApS | 4,305,131 9.800% | 4,305,131 (New Position) | Filing History |
| 2023-02-09 11:37 am Purchase | 2022-12-30 | 13G | Y-mAbs Therapeutics, Inc. YMAB | The Vanguard Group | 2,258,254 5.170% | 2,258,254 (New Position) | Filing History |
| 2023-02-01 4:54 pm Sale | 2022-12-31 | 13G | Y-mAbs Therapeutics, Inc. YMAB | BlackRock Inc. BLK | 2,578,776 5.900% | -188,584 (-6.81%) | Filing History |
| 2022-04-11 08:51 am Sale | 2022-03-31 | 13G | Y-mAbs Therapeutics, Inc. YMAB | Wellington Management Group LLP | 1,910,578 4.370% | -2,360,804 (-55.27%) | Filing History |
| 2022-02-14 6:45 pm Purchase | 2021-11-04 | 13D | Y-mAbs Therapeutics, Inc. YMAB | Sofinnova Venture Partners X L.P. | 2,271,611 5.200% | 160,222 (+7.59%) | Filing History |
| 2022-02-07 5:13 pm Purchase | 2021-12-31 | 13G | Y-mAbs Therapeutics, Inc. YMAB | HBM Healthcare Investments (Cayman) Ltd. | 3,090,954 7.100% | 960,581 (+45.09%) | Filing History |
| 2022-02-04 09:30 am Sale | 2021-12-31 | 13G | Y-mAbs Therapeutics, Inc. YMAB | Wellington Management Group LLP | 4,271,382 9.790% | -177,228 (-3.98%) | Filing History |
| 2022-02-03 4:41 pm Purchase | 2021-12-31 | 13G | Y-mAbs Therapeutics, Inc. YMAB | BlackRock Inc. BLK | 2,767,360 6.300% | 348,780 (+14.42%) | Filing History |
| 2021-07-12 09:24 am Purchase | 2021-06-30 | 13G | Y-mAbs Therapeutics, Inc. YMAB | Wellington Management Group LLP | 4,448,610 10.210% | 2,008,801 (+82.33%) | Filing History |
| 2021-02-12 4:00 pm Sale | 2020-12-31 | 13G | Y-mAbs Therapeutics, Inc. YMAB | HBM Healthcare Investments (Cayman) Ltd. | 2,130,373 5.300% | -657,452 (-23.58%) | Filing History |
| 2021-02-04 11:48 am Sale | 2020-12-31 | 13G | Y-mAbs Therapeutics, Inc. YMAB | Wellington Management Group LLP | 2,439,809 6.020% | -16,817 (-0.68%) | Filing History |
| 2021-02-02 3:13 pm Purchase | 2020-12-31 | 13G | Y-mAbs Therapeutics, Inc. YMAB | BlackRock Inc. BLK | 2,418,580 6.000% | 452,462 (+23.01%) | Filing History |